首页> Nature genetics> A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

导出 LinkOut

翻译打印收藏纠错

第一作者： Laura,Fachal

第一单位： 1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.

作者： Laura,Fachal ^[1] ; Antonio,Gómez-Caamaño ^[2] ; Gillian C,Barnett ^[3] ; Paula,Peleteiro ^[2] ; Ana M,Carballo ^[2] ; Patricia,Calvo-Crespo ^[2] ; Sarah L,Kerns ^[4] ; Manuel,Sánchez-García ^[5] ; Ramón,Lobato-Busto ^[5] ; Leila,Dorling ^[3] ; Rebecca M,Elliott ^[6] ; David P,Dearnaley ^[7] ; Matthew R,Sydes ^[8] ; Emma,Hall ^[9] ; Neil G,Burnet ^[10] ; Ángel,Carracedo ^[11] ; Barry S,Rosenstein ^[4] ; Catharine M L,West ^[6] ; Alison M,Dunning ^[3] ; Ana,Vega ^[1]

作者单位： 1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain. ^[1] Department of Radiation Oncology, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain. ^[2] Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. ^[3] Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. ^[4] Department of Medical Physics, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain. ^[5] Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK. ^[6] Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, UK. ^[7] Cancer and Other Non-Infectious Diseases, Medical Research Council (MRC) Clinical Trials Unit, London, UK. ^[8] Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK. ^[9] Department of Oncology, University of Cambridge, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ^[10] 1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain. [3] Center of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Jeddah, Saudi Arabia. ^[11]